Many factors including the localization of NRF2 in the tumor tissue, the stages of cancer, the therapy response of the cancer, and the metabolic properties of the cancer determine the anti-tumor or pro-tumor activity of NRF2. The gene discussed is NFE2L2; the disease is cancer.